Press Releases 2025 2024 2023 2022 2021 2020 2019 all January 10, 2025 Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational Expansion Cohort to Support Potential Submission for U.S. Accelerated Approval for DYNE-101 in DM1 in H1 2026 January 9, 2025 Dyne Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference January 8, 2025 Dyne Therapeutics to Host Investor Conference Call and Webcast to Review New Clinical Data from the ACHIEVE Trial Friday, January 10 at 8:00 a.m. ET
